Summary of Key Information:

Reporting Period (Quarter/Year): Quarter and Half Year ended September 30, 2026 (Q2 FY27, H1 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 of SEBI Listing Regulations

Date of Board Meeting / Approval: November 02, 2026 (Meeting held from 12:27 PM IST to 01:20 PM IST)

Audit Opinion: Clean, Unmodified Limited Review Report

Auditor’s Comment: Nothing has come to our attention that causes us to believe that the Statement contains any material misstatement. (Deloitte Haskins & Sells LLP)

Key Financial Highlights [Unit: ₹ Lakhs]

Standalone Results:

Revenue from Operations:

  • Q2 FY27: ₹8,895.91 Lakhs (vs. Q2 FY26: ₹7,734.49 Lakhs | +15.0% YoY)
  • H1 FY27: ₹15,903.59 Lakhs (vs. H1 FY26: ₹13,811.90 Lakhs | +15.1% YoY)

Total Income:

  • Q2 FY27: ₹8,957.00 Lakhs
  • H1 FY27: ₹16,036.56 Lakhs

Net Profit:

  • Q2 FY27: ₹733.39 Lakhs (vs. Q2 FY26: ₹554.36 Lakhs | +32.3% YoY)
  • H1 FY27: ₹1,287.75 Lakhs (vs. H1 FY26: ₹983.94 Lakhs | +30.9% YoY)

EPS (not annualised for quarters):

  • Basic & Diluted Q2 FY27: ₹3.77
  • Basic & Diluted H1 FY27: ₹6.62

Other Equity: ₹4,37,954.42 Lakhs (as at March 31, 2026)

Cash and Cash Equivalents: ₹1,730.64 Lakhs (as at September 30, 2026; down from ₹11,452.76 Lakhs as at March 31, 2026)

Debt: Short-term borrowings of ₹3,869.62 Lakhs reported under current liabilities. No long-term borrowings specified.

Consolidated Results:

Revenue from Operations:

  • Q2 FY27: ₹8,884.70 Lakhs (vs. Q2 FY26: ₹7,720.79 Lakhs | +15.1% YoY)
  • H1 FY27: ₹15,888.73 Lakhs (vs. H1 FY26: ₹13,799.49 Lakhs | +15.1% YoY)

Net Profit attributable to Owners:

  • Q2 FY27: ₹740.95 Lakhs (vs. Q2 FY26: ₹628.96 Lakhs | +17.8% YoY)
  • H1 FY27: ₹1,310.72 Lakhs (vs. H1 FY26: ₹1,015.75 Lakhs | +29.0% YoY)

EPS (not annualised for quarters):

  • Basic & Diluted Q2 FY27: ₹3.81
  • Basic & Diluted H1 FY27: ₹6.74

Segment-wise Performance:

The Company is primarily engaged in the business of Health and Hygiene products and services. As per Ind AS 108, there is no other separate reportable segment, as the chief operating decision maker reviews the business as a whole.

Corporate Actions:

Dividend: Not Specified

Other Corporate Actions: The Board approved the re-appointment of Mr. Homi Katgara (DIN: 00210338) as a Non-Executive, Independent Director for a second term of 5 consecutive years, commencing January 31, 2027, to January 30, 2032, subject to shareholder approval.

Other Significant Information:

Exceptional Items:

  • A reversal of gratuity expense of ₹1,953.77 Lakhs was recorded as exceptional income in Q1 FY27, following an amendment to the gratuity scheme to align with the Payment of Gratuity Act, 1972. [Non-Recurring]
  • For FY26, an exceptional expense of ₹4,044.18 Lakhs was recorded related to the incremental impact on retiral benefits from the newly notified Labour Codes. [Non-Recurring]

Employee Stock Options: Employee benefit expense includes a charge for equity-settled share-based payments of ₹663.16 Lakhs for Q2 FY27 and ₹1,319.13 Lakhs for H1 FY27.

Subsidiaries: The consolidated results include subsidiaries: Infinite Water Solutions Pvt. Ltd., ForbesAquatech Ltd., Euro Forbes Ltd., and Forbes Lux FZE (up to November 13, 2025). The review report relies on the work of other auditors for one material subsidiary.

Cash Flow: Significant net decrease in cash and cash equivalents from operating and investing activities for both standalone (Net decrease: ₹9,722.12 Lakhs) and consolidated (Net decrease: ₹10,498.98 Lakhs) entities for H1 FY27.